Prosecution Insights
Last updated: August 16, 2026
Application No. 17/288,147

Needle Cover for a Medical Injection Device

Non-Final OA §103
Filed
Apr 23, 2021
Priority
Oct 26, 2018 — EU 18306403.9 +1 more
Examiner
ZAMORY, JUSTIN L
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Becton Dickinson France
OA Round
7 (Non-Final)
73%
Grant Probability
Favorable
7-8
OA Rounds
0m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
371 granted / 510 resolved
+2.7% vs TC avg
Strong +17% interview lift
Without
With
+17.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
45 currently pending
Career history
564
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
56.1%
+16.1% vs TC avg
§102
19.1%
-20.9% vs TC avg
§112
15.2%
-24.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 510 resolved cases

Office Action

§103
DETAILED ACTION Response to Arguments Applicant’s arguments, see Appeal Brief, filed March 31, 2026, with respect to the rejection(s) of claim(s) 1-15 under 35 U.S.C. 103 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is set forth below. The same series of references is being relied upon; however, Brunel has been removed and replaced with Lowe to teach the ribs on the cap member which are engaged with central portion of a bulge on a needle hub. Lowe clearly teaches such annular engagement features to be used in addition to a proximal retaining flange thereby providing clear motivation to modify Prais to include such ribs to increase the frictional engagement of the cap on the central portion of a needle hub expanded portion. The current rejection is considered to teach the claimed device as currently set forth and has overcome any arguments as to reversal of parts or the propriety of the previously cited combination of references. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-3, 5-7, and 9-15 are is/are rejected under 35 U.S.C. 103 as being unpatentable over Prais et al. (US 2001/0039402) in view of Lowe et al. (US 4,735,311), and further in view of Kawachi (US 2013/0012886). Regarding claims 1-3 and 14, Prais et al. (henceforth Prais) discloses (Figures 1-3) a needle cover (22) for protecting a needle (30) mounted on a tip (Figure 2) of a medical injection device, wherein the tip comprises a distal bulge (26; it is noted that the medical injection device and its tip are not positively recited and for this reason the needle cover need only be capable of performing the claimed functions), the needle cover comprising an inner needle shield made of a material with elastomeric properties (¶ [0029]), the inner needle shield comprising a first portion, a second portion, and a third portion (terminal portion of cap adjacent needle tip after installation), the third portion being distal to the second portion being distal to the first portion and having an inner sealing portion (inner surface; 50, 52, and 54) within the second portion configured to sealingly contact an outer surface of the bulge (¶ [0029]), wherein the inner sealing portion comprises one or more ribs (e.g., 52 as a rounded internal surface for engaging the needle tip, Figure 2, the rib contacts the proximal surface of bulge 26) extending inwardly along a circumference of the inner sealing portion (Figure 3), at least one rib of the one or more ribs, being a continuous rib in the form of a ring configured to provide a continuous contact with the outer surface of the distal bulge (Figures 2-3; ¶ [0029]), and the first portion having a greater outer diameter than an outer diameter of the second portion, the first portion configured to include a space between the first portion and the tip (see annotated figure below, there is a gap between the hub shaft and the inner surface of the first portion) . Prais fails to explicitly disclose the inner sealing portion of the second portion as comprising one or more ribs configured to seal with a central portion of the outer most surface of the bulge as claimed as well as the third portion configured to accommodate the needle and so that the needle is pricked into a distal part of the third portion. PNG media_image1.png 206 264 media_image1.png Greyscale Lowe et al. (henceforth Lowe) teaches (Figures 5 and 7) a cover for protecting a needle which comprises a plurality of ribs (66; Figure 7 depicts two rounded annular ribs as per claims 2, 3, and 14) formed on an inner surface thereof and engaged with the central portion of a bulge on the needle end (Figure 7; it can be seen in Figure 7 that the ribs 66 on the inner cap portion of Lowe are engaged with a central section of an expanded hub on the distal end of the throat portion 54; needle hub has an enlarged head portion 50 which is engaged by ribs 66 after connecting the cap to the hub; Col. 3, lines 54-66; this includes a central, largest diameter portion). It would have been obvious to one of ordinary skill in the art at the time of filing to modify the cap of Prais to comprise two sealing ribs along the central section engaged with the central surface of a bulge, as taught by Lowe so as to provide a number of annular sealing rib surfaces for engaging a bulge portion of the syringe tip for retaining the cap thereon as taught by Lowe (Col. 3, lines 54-66). Lowe teaches that two ribs are sufficient for retaining a cover on a needle assembly and it would therefore be obvious to utilize only two ribs as claimed to securely retain the cap on the tip portion as taught by Lowe. In such a combination, the cap of Prais would be modified to provide the sealing ribs of Lowe along a central section of the cap to engage with the bulge in the same manner disclosed by Lowe. This would provide additional frictional engagement between the cap and hub while retaining the primary function of the device of Prais which is to inhibit the removal of the cap until a sufficient force is generated to do so. It is further noted that Lowe teaches the circumferential ribs 66 as used along with proximal rib 58 with bevel 62 which abuts a proximal surface of the hub 50 during use, and which is analogous to element 52 of Prais. Regarding the third, tapered portion for receiving the needle, Lowe further teaches the use of a portion of the cover which comprises a space for receiving the needle (element 24 of Lowe; Figure 2). However, Prais/Lowe fail to explicitly teach the portion of the cap for receiving the needle tip which tapers from the second portion to a distal end of the needle cover. However, Kawachi teaches (Figures 4-5) a needle cap (10) for a syringe (20) comprising a distal portion (12A, analogous to the third portion of Prais) for receiving the needle tip (22) in a piercing, or pricked, configuration after covering the needle tip with the cap (¶ [0011]). It would have been obvious to one of ordinary skill in the art at the time of filing to utilize the elastomeric needle tip receiving section of Kawachi at the third, tapered portion of Prais so as to allow a user to safely cover the needle while providing a means of determining possible curvature or breakage of the syringe needle between uses via the transparent cap and elastomer means as taught by Kawachi (¶ [0011]). Regarding claim 5, Prais/Lowe further discloses wherein each rib (52 and 66 of Lowe) extends inwardly in an orthogonal direction relative to a longitudinal axis of the needle shield (Figure 3 of Prais and Figure 7 of Lowe; the ribs are annular extensions which reduce the inner diameter of the cap for sealing against the hub). Regarding claim 6, Prais/Lowe further discloses wherein each rib (52 of Prais and 66 of Lowe) is in the form of a continuous ring configured to provide a continuous contact with the outer surface of the bulge (Figure 3 of Prais; Figure 7 of Lowe, the ribs are continuous annular rings extending around the inner surface of the cap). Regarding claim 7, Prais further discloses wherein the material is a thermoplastic elastomer (¶ [0030]). Regarding claim 9, Prais/Lowe further disclose wherein the continuous rib is rotationally symmetrical with respect to an axis of the needle cover (Figure 7 of Lowe, the ribs are concentric about an inner surface of the needle cover as depicted). Regarding claim 10, Prais further discloses an outer needle shield (outer surface of 22) surrounding, at least partially, the inner needle shield (the inner needle shield may be considered as the inner surface of 22 and therefore the outer surface may be considered the outer shield as claimed). Regarding claim 11, Prais discloses a medical assembly (Figures 1-3) comprising: a medical injection device (Figure 1) comprising: a main body defining a container (syringe barrel) for containing a medical composition (44), a tip (26) extending distally from the main body, defining a fluid path extending through the tip and in fluid communication with the container (Figure 2), wherein said tip comprises a distal bulge (radially extending portion of 26 as depicted in Figure 2), a needle (30) attached to the tip and in fluid communication with the fluid path; a needle cover (22) for protecting a needle (30) mounted on a tip (Figure 2) of a medical injection device, wherein the tip comprises a distal bulge (26; it is noted that the medical injection device and its tip are not positively recited and for this reason the needle cover need only be capable of performing the claimed functions), the needle cover comprising an inner needle shield made of a material with elastomeric properties (¶ [0029]), the inner needle shield comprising a first portion, a second portion, and a third portion (terminal portion of cap adjacent needle tip after installation), the third portion being distal to the second portion being distal to the first portion and having an inner sealing portion (inner surface; 50, 52, and 54) within the second portion configured to sealingly contact an outer surface of the bulge (¶ [0029]), wherein the inner sealing portion comprises one or more ribs (e.g., 52 as a rounded internal surface for engaging the needle tip, Figure 2, the rib contacts the proximal surface of bulge 26) extending inwardly along a circumference of the inner sealing portion (Figure 3), at least one rib being a continuous rib in the form of a ring configured to provide a continuous contact with the outer surface of the distal bulge (Figures 2-3; ¶ [0029]), and the first portion having a greater outer diameter than an outer diameter of the second portion, the first portion configured to include a space between the first portion and the tip (see annotated figure below, there is a gap between the hub shaft and the inner surface of the first portion) . Prais fails to explicitly disclose the inner sealing portion of the second portion as comprising one or more ribs configured to seal with a central portion of the outer most surface of the bulge as claimed as well as the third portion configured to accommodate the needle and so that the needle is pricked into a distal part of the third portion. PNG media_image1.png 206 264 media_image1.png Greyscale Lowe et al. (henceforth Lowe) teaches (Figures 5 and 7) a cover for protecting a needle which comprises a plurality of ribs (66) formed on an inner surface thereof (Figure 7; it can be seen in Figure 7 that the ribs 66 on the inner cap portion of Lowe are engaged with a central section of an expanded hub on the distal end of the throat portion 54; needle hub has an enlarged head portion 50 which is engaged by ribs 66 after connecting the cap to the hub; Col. 3, lines 54-66). It would have been obvious to one of ordinary skill in the art at the time of filing to modify the cap of Prais to comprise two sealing ribs along the central section engaged with the central surface of a bulge, as taught by Lowe so as to provide a number of annular sealing rib surfaces for engaging a bulge portion of the syringe tip for retaining the cap thereon as taught by Lowe (Col. 3, lines 54-66). Lowe teaches that two ribs are sufficient for retaining a cover on a needle assembly and it would therefore be obvious to utilize only two ribs as claimed to securely retain the cap on the tip portion as taught by Lowe. In such a combination, the cap of Prais would be modified to provide the sealing ribs of Lowe along a central section of the cap to engage with the bulge in the same manner disclosed by Lowe. This would provide additional frictional engagement between the cap and hub while retaining the primary function of the device of Prais which is to inhibit the removal of the cap until a sufficient force is generated to do so. Regarding the third, tapered portion for receiving the needle, Lowe further teaches the use of a portion of the cover which comprises a space for receiving the needle (element 24 of Lowe; Figure 2). However, Prais/Lowe fail to explicitly teach the portion of the cap for receiving the needle tip which tapers from the second portion to a distal end of the needle cover. However, Kawachi teaches (Figures 4-5) a needle cap (10) for a syringe (20) comprising a distal portion (12A, analogous to the third portion of Prais) for receiving the needle tip (22) in a piercing, or pricked, configuration after covering the needle tip with the cap (¶ [0011]). It would have been obvious to one of ordinary skill in the art at the time of filing to utilize the elastomeric needle tip receiving section of Kawachi at the third, tapered portion of Prais so as to allow a user to safely cover the needle while providing a means of determining possible curvature or breakage of the syringe needle between uses via the transparent cap and elastomer means as taught by Kawachi (¶ [0011]). Regarding claim 12, Prais further discloses wherein the tip of the medical injection device is made of glass (see e.g., ¶ [0027] discloses that the barrel, the distal portion of which forms part of the tip section of the device, is formed from glass). Regarding claim 13, Prais/Lowe further discloses wherein the sealing portion comprises one or two ribs (52; Figure 2; see also Figure 7 of Lowe which depicts two ribs engaged with hub 50). Regarding claim 15, Prais discloses a medical assembly comprising: a medical injection device (syringe) comprising: a main body defining a container (inside of 24) for containing a medical composition (44), a tip (hub comprising 26) extending distally from the main body (Figure 2), defining a fluid path extending through the tip and in fluid communication with the container, wherein said tip comprises a distal bulge (26) distal to a cylindrical portion of the tip, the distal bulge having an outer surface, a needle (30) attached to the tip and in fluid communication with the fluid path; a needle cover (22) comprising an inner needle shield (inner surface of 22) made of a material with elastomeric properties (¶ [0029]), the inner needle shield comprising a first portion, a second portion, and a third portion, the third portion being distal to the second portion (see annotated figure below) and having an internal surface that tapers from the second portion to a distal end of the needle cover (the third portion can be seen to be conical and therefore tapers toward the distal end as claimed) the second portion being distal to the first portion (see annotated figure below) and having an inner sealing portion configured to sealingly contact the outer most surface of the distal bulge (it contacts the most proximal surface of 26 as depicted in Figure 2), wherein the inner sealing portion comprises one or more ribs (52) extending inwardly along a circumference of the inner sealing portion, at least one rib of the one or more ribs, being a continuous rib in the form of a ring (Figure 2, element 52 is a flange configured to engage the proximal surface of the bulge to retain the cap on the tip) configured to provide a continuous contact with a portion of the outer most surface of the distal bulge, mounted on the tip of the medical injection device. Prais does not explicitly disclose wherein one or more ribs of the inner sealing portion of the inner needle shield sealingly contact the central portion of the outer most surface of the distal bulge or the piercing of the needle into a distal part of the third portion. PNG media_image1.png 206 264 media_image1.png Greyscale Lowe et al. (henceforth Lowe) teaches (Figures 5 and 7) a cover for protecting a needle which comprises a plurality of ribs (66) formed on an inner surface thereof (Figure 7; it can be seen in Figure 7 that the ribs 66 on the inner cap portion of Lowe are engaged with a central section of an expanded hub on the distal end of the throat portion 54; needle hub has an enlarged head portion 50 which is engaged by ribs 66 after connecting the cap to the hub; Col. 3, lines 54-66; this includes a central, largest diameter portion). It would have been obvious to one of ordinary skill in the art at the time of filing to modify the cap of Prais to comprise two sealing ribs along the central section engaged with the central surface of a bulge, as taught by Lowe so as to provide a number of annular sealing rib surfaces for engaging a bulge portion of the syringe tip for retaining the cap thereon as taught by Lowe (Col. 3, lines 54-66). Lowe teaches that two ribs are sufficient for retaining a cover on a needle assembly and it would therefore be obvious to utilize only two ribs as claimed to securely retain the cap on the tip portion as taught by Lowe. In such a combination, the cap of Prais would be modified to provide the sealing ribs of Lowe along a central section of the cap to engage with the bulge in the same manner disclosed by Lowe. This would provide additional frictional engagement between the cap and hub while retaining the primary function of the device of Prais which is to inhibit the removal of the cap until a sufficient force is generated to do so. It is further noted that Lowe teaches the circumferential ribs 66 as used along with proximal rib 58 with bevel 62 which abuts a proximal surface of the hub 50 during use and which is analogous to element 52 of Prais. Regarding the third, tapered portion for receiving the needle, Lowe further teaches the use of a portion of the cover which comprises a space for receiving the needle (element 24 of Lowe; Figure 2). However, Prais/Lowe fail to explicitly teach the portion of the cap for receiving the needle tip which tapers from the second portion to a distal end of the needle cover. However, Kawachi teaches (Figures 4-5) a needle cap (10) for a syringe (20) comprising a distal portion (12A, analogous to the third portion of Prais) for receiving the needle tip (22) in a piercing, or pricked, configuration after covering the needle tip with the cap (¶ [0011]). It would have been obvious to one of ordinary skill in the art at the time of filing to utilize the elastomeric needle tip receiving section of Kawachi at the third, tapered portion of Prais so as to allow a user to safely cover the needle while providing a means of determining possible curvature or breakage of the syringe needle between uses via the transparent cap and elastomer means as taught by Kawachi (¶ [0011]). Claim(s) 4 and 8 are is/are rejected under 35 U.S.C. 103 as being unpatentable over Prais in view of Lowe, and further in view of Brunel et al. (US 2020/0121864). Regarding claims 4 and 8, Prais/Lowe teach the claimed invention substantially as set forth above for claim 1, and Lowe further teaches that the inner sealing portion comprises two or three ribs (see Figure 7, there are two ribs 66 depicted). However, Prais/Lowe are silent regarding the height of the ribs as being within the claimed range of 0.1 mm and 0.4 mm or the spacing of the rib being within the claimed range of between 0.4 mm and 2.8 mm and preferably between 0.4 mm and 1.2 mm. Brunel et al. (henceforth Brunel) teaches (Figure 3) a tip portion of a syringe comprising annular ribs (48) which are disclosed as having a height of between 0.1 mm and 0.4 mm (¶ [0042]) and a spacing between 0.4 mm and 1.2 mm (¶ [0041]). It would have been obvious to one of ordinary skill in the art at the time of filing to modify the sealing rib of Prais/Lowe to be of the claimed height as Brunel teaches that such dimensions and spacings are known for use in sealing ribs on medical devices and would be advantageous depending on the fit required by the different elements during design of such a device. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JUSTIN L ZAMORY whose telephone number is (571)270-1238. The examiner can normally be reached M-F 8:30am-4:30pm ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Tsai can be reached at 571-270-5246. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JUSTIN L ZAMORY/Examiner, Art Unit 3783 /MICHAEL J TSAI/Supervisory Patent Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Show 27 earlier events
Feb 25, 2026
Response after Non-Final Action
Mar 31, 2026
Response after Non-Final Action
Mar 31, 2026
Response after Non-Final Action
Apr 18, 2026
Response after Non-Final Action
Apr 27, 2026
Response after Non-Final Action
May 20, 2026
Response after Non-Final Action
May 22, 2026
Response after Non-Final Action
Jul 30, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702790
REUSABLE URINARY CATHETER KITS
4y 8m to grant Granted Aug 11, 2026
Patent 12667695
APPARATUSES AND METHODS FOR TRACKING OBSTRUCTIVE MATERIAL WITHIN A SUCTION CATHETER
1y 8m to grant Granted Jun 30, 2026
Patent 12653956
LIQUID DELIVERY CAP WITH ALIGNMENT VERIFICATION
4y 5m to grant Granted Jun 16, 2026
Patent 12642910
SYSTEM AND METHOD FOR SAFETY SYRINGE
4y 11m to grant Granted Jun 02, 2026
Patent 12589204
Artificial Pancreas Integrated CGM Architectures and Designs
4y 6m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8
Expected OA Rounds
73%
Grant Probability
90%
With Interview (+17.4%)
3y 4m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 510 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month